Section 122E(ii) in The Drugs and Cosmetics Rules, 1945
(ii)a new drug shall continue to be considered as new drug for a period of four years from the date of its first approval [***] [Omitted by Notification No. G.S.R. 724 (E) dated 7.11.2013 (w.e.f. 21.12.1945)].
